News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Roche Holding AG (RHHBF.PK) and AstraZeneca PLC (AZN) Face Tussle Over Lung Cancer Pills; Roche To Start New Trial With Tarceva In Lung Cancer


4/24/2009 7:43:03 AM

Bookmark and Share

ZURICH (Dow Jones)--Swiss pharmaceutical company Roche Holding AG (ROG.VX) said Friday it will start a new trial for Tarceva in lung cancer patients with a certain form of gene mutation, challenging a similar drug candidate from U.K.-rival AstraZeneca PLC (AZN) that got a positive European Union panel recommendation Thursday.


Read at Reuters
Read at Wall Street Journal

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES